A truncated cytoplasmic topoisomerase IIalpha in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34.
about
P1343
Nuclear interactions of topoisomerase II alpha and beta with phospholipid scramblase 1DNA topoisomerase II as a target for cancer chemotherapy.DNA topoisomerase II is involved in regulation of cyst wall protein genes and differentiation in Giardia lamblia.Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks.Modulation of drug sensitivity in yeast cells by the ATP-binding domain of human DNA topoisomerase IIalphaCharacterization of human NSCLC cell line with innate etoposide-resistance mediated by cytoplasmic localization of topoisomerase II alpha.Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.
P2860
Q24310373-2AE0BC6C-9053-4A3F-A6DF-F97956A63742Q34718447-7950BBD9-635E-4BCD-9292-91BC02305C33Q34734263-99CB6BDE-6C3D-4DAD-9A24-CB40622E8AF1Q35222177-3B18C37B-7DD3-46FC-B878-73226B04BC95Q36118901-43DF5916-82FD-4D98-AEB8-81115F2EAA13Q40354662-68D0E593-7C9B-47F7-B538-04318D983F15Q41882926-A22EB711-248B-4D5A-98E2-366B6654DCDEQ47905169-6E1807E0-3503-4191-A97E-9D971C57DB90
P2860
A truncated cytoplasmic topoisomerase IIalpha in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
A truncated cytoplasmic topois ...... a partial deletion of exon 34.
@en
type
label
A truncated cytoplasmic topois ...... a partial deletion of exon 34.
@en
prefLabel
A truncated cytoplasmic topois ...... a partial deletion of exon 34.
@en
P2093
P2860
P1476
A truncated cytoplasmic topois ...... a partial deletion of exon 34.
@en
P2093
B G Campling
K E Sparks
S E Mirski
P2860
P304
P356
10.1002/(SICI)1097-0215(20000215)85:4<534::AID-IJC15>3.0.CO;2-X
P4510
P577
2000-02-01T00:00:00Z